45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,695
Insurances with rates
16
CPT / HCPCS codes
2,641
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 108956_ERX | INJECTION, IPILIMUMAB, 1 MG | $109,659 | $65,796 | — | — | 17 |
| 198794_ERX | BRACHYTHERAPY SOURCE, NON-STRANDED, YTTRIUM-90, PER SOURCE | $65,583 | $39,350 | — | — | 17 |
| 102951 | SIPULEUCEL-T, MINIMUM OF 50 MILLION AUTOLOGOUS CD54+ CELLS ACTIVATED WITH PAP-GM-CSF, INCLUDING LEUK | $59,336 | $35,602 | — | — | 14 |
| 107664_ERX | INJECTION, PEGLOTICASE, 1 MG | $58,638 | $35,183 | — | — | 17 |
| 168184_ERX | INJECTION, POLATUZUMAB VEDOTIN-PIIQ, 1 MG | $56,918 | $34,151 | — | — | 17 |
| 143828 | Insertion or replacement of defibrillator with electrode | $47,318 | $28,391 | — | — | 17 |
| 184158_ERX | INJECTION, NIVOLUMAB AND RELATLIMAB-RMBW, 3 MG/1 MG | $46,693 | $28,016 | — | — | 17 |
| 143882 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chambe | $45,239 | $27,143 | — | — | 17 |
| 118394 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $44,873 | $26,924 | — | — | 17 |
| 143886 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $44,873 | $26,924 | — | — | 17 |
| 105644_ERX | INJECTION, CABAZITAXEL, 1 MG | $44,562 | $26,737 | — | — | 17 |
| 143880 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chambe | $44,054 | $26,432 | — | — | 17 |
| 162632_ERX | INJECTION, TILDRAKIZUMAB, 1 MG | $42,068 | $25,241 | — | — | 17 |
| 143806 | Insertion of defibrillator with existing multiple leads | $40,824 | $24,494 | — | — | 17 |
| 143820 | Insertion of implantable defibrillator system | $40,824 | $24,494 | — | — | 17 |
| 143826 | Removal and replacement of multiple lead defibrillator | $40,824 | $24,494 | — | — | 17 |
| 137896_ERX | INJECTION, OCRELIZUMAB, 1 MG | $39,429 | $23,657 | — | — | 17 |
| 174456_ERX | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $38,342 | $23,005 | — | — | 17 |
| 143898 | Repair of left upper heart chamber with implant with review by radiologist | $37,347 | $22,408 | — | — | 17 |
| 111348_ERX | INJECTION, BRENTUXIMAB VEDOTIN, 1 MG | $36,987 | $22,192 | — | — | 17 |
| 127561_ERX | INJECTION, IMMUNE GLOBULIN, (GAMUNEX-C/GAMMAKED), NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $36,661 | $21,997 | — | — | 17 |
| 132613_ERX | INJECTION, ATEZOLIZUMAB, 10 MG | $34,411 | $20,647 | — | — | 17 |
| 144160 | Repair of congenital abnormality in wall between upper heart chambers with implant | $34,077 | $20,446 | — | — | 17 |
| 164576_ERX | INJECTION, CEMIPLIMAB-RWLC, 1 MG | $33,411 | $20,047 | — | — | 17 |
| 192708_ERX | INJECTION, GLOFITAMAB-GXBM, 2.5 MG | $33,155 | $19,893 | — | — | 17 |
| 27387_SUP | TRANSCATH HEART VALVE 23MM SAPIEN 3 S3UCM223A | $32,500 | $19,500 | — | — | 14 |
| 27388_SUP | TRANSCATH HEART VALVE 26MM SAPIEN 3 S3UCM226A | $32,500 | $19,500 | — | — | 14 |
| 27389_SUP | TRANSCATH HEART VALVE 29MM SAPIEN 3 9600CM29A | $32,500 | $19,500 | — | — | 14 |
| 143900 | Replacement of aortic valve through the skin and femoral artery | $32,475 | $19,485 | — | — | 17 |
| 143904 | Replacement of aortic valve through axillary artery | $32,475 | $19,485 | — | — | 17 |
| 195907 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $32,475 | $19,485 | — | — | 14 |
| 173322_ERX | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $31,413 | $18,848 | — | — | 17 |
| 132483_ERX | RADIUM RA-223 DICHLORIDE, THERAPEUTIC, PER MICROCURIE | $30,424 | $18,254 | — | — | 17 |
| 162886_ERX | INJECTION, PATISIRAN, 0.1 MG | $29,925 | $17,955 | — | — | 17 |
| 121581 | Insertion of permanent leadless pacemaker using imaging guidance | $29,859 | $17,915 | — | — | 17 |
| 27419_SUP | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $29,490 | $17,694 | — | — | 15 |
| 143804 | Insertion of defibrillator with existing dual leads | $29,292 | $17,575 | — | — | 17 |
| 143814 | Insertion of defibrillator with existing single lead | $29,292 | $17,575 | — | — | 17 |
| 143822 | Removal and replacement of single lead defibrillator | $29,292 | $17,575 | — | — | 17 |
| 143824 | Removal and replacement of dual lead defibrillator | $29,292 | $17,575 | — | — | 17 |
| 141492 | Removal of plaque and insertion of stents in arteries of leg | $29,064 | $17,438 | — | — | 15 |
| 20177_SUP | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $28,612 | $17,167 | — | — | 15 |
| 108955_ERX | INJECTION, IPILIMUMAB, 1 MG | $27,415 | $16,449 | — | — | 17 |
| 118421 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary vessel with distal | $26,614 | $15,968 | — | — | 17 |
| 144074 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary vessel with distal | $26,614 | $15,968 | — | — | 17 |
| 185076 | Insertion of wireless pressure sensor into lung artery through tube with review by radiologist | $26,475 | $15,885 | — | — | 17 |
| 28429_SUP | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), HIGH FREQUENCY, WITH RECHARGEABLE BATTERY AND CHARGING SYS | $26,000 | $15,600 | — | — | 15 |
| 124767_ERX | INJECTION, OBINUTUZUMAB, 10 MG | $25,962 | $15,577 | — | — | 17 |
| 174455_ERX | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $25,560 | $15,336 | — | — | 17 |
| 28965_ERX | SAMARIUM SM 153 LEXIDRONAM 1850 MBQ/ML IV SOLN | $25,442 | $15,265 | — | — | 14 |
Showing top 50 of 12,695 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.